[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].

Hilbe W, Aigner K, Dittrich C, Eckmayr J, Fiegl M, Flicker M, Forstner B, Greil R, Jamnig H, Krajnik G, Lang A, Mohn-Staudner A, Schinko H, Studnicka M, Pirker R, Ploner F, Rothmund J, Schiller L, Zabernigg A, Zöchbauer-Müller S.

http://www.ncbi.nlm.nih.gov/pubmed/17492355